Core Viewpoint - Amgen has declared a dividend of $2.52 per share for the second quarter of 2026, reflecting its commitment to returning value to shareholders [1]. Company Overview - Amgen is a biotechnology company that discovers, develops, manufactures, and delivers innovative medicines targeting serious diseases [1]. - The company has been a pioneer in the biotechnology industry for over 45 years and continues to leverage technology and human genetic data for innovation [1]. - Amgen's portfolio includes treatments for cancer, heart disease, inflammatory conditions, rare diseases, and obesity-related conditions [1]. Financial Information - The dividend will be paid on June 5, 2026, to stockholders of record as of May 15, 2026 [1]. - Amgen is part of the Dow Jones Industrial Average and the Nasdaq-100 Index, indicating its significant market capitalization and innovation [1]. Recent Developments - Amgen is recognized for its innovation and workplace culture, receiving accolades from Fast Company and Forbes [1]. - The company is advancing a broad pipeline of medicines, indicating ongoing research and development efforts [1].